Abstract
Renal cell carcinoma (RCC) accounts for 2% of all human cancer, but familial cases are infrequent. Riches (1963) and Griffin et al. (1984) in a population-based case-control study found a family history of renal cell carcinoma in 2.4% of affected patients compared to 1.4% of controls. Nevertheless the importance of inherited tumours in clinical practice and medical research is disproportionate to their frequency. In clinical practice recognition of familial RCC can provide opportunities to prevent morbidity and mortality by appropriate screening. In medical research recent advances in molecular genetics offer the prospect of isolating the genes involved in the pathogenesis of familial RCC and of the more common sporadic cases. In this article we review the clinical and molecular genetics of inherited renal cell carcinoma (adenocarcinoma or hypernephroma).
Article PDF
Rights and permissions
About this article
Cite this article
Maher, E., Yates, J. Familial renal cell carcinoma: clinical and molecular genetic aspects. Br J Cancer 63, 176–179 (1991). https://doi.org/10.1038/bjc.1991.43
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.43
This article is cited by
-
Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer
Hereditary Cancer in Clinical Practice (2005)
-
Molekulare Diagnostik von Erkrankungen der Niere mit genetischer Prädisposition
Der Urologe (2003)